Online hemodiafiltration

Artificial Organs

Volumn 30, Issue 8, 2006, Pages 579-585

  Van Laecke, Steven ^a   De Wilde, Katrien ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Mortality; Online hemodiafiltration; Renal failure; Solute removal; Ultrapure dialysate; Uremic toxins

Indexed keywords

BIOCOMPATIBILITY; DIALYSIS MEMBRANES;

DIALYSATES; HEMODIAFILTRATION; LARGE AMOUNTS; MORTALITY; ONLINE HEMODIAFILTRATION; RENAL FAILURE; SOLUTE REMOVAL; ULTRAPURE; ULTRAPURE DIALYZATE; UREMIC TOXINS;

DIALYSIS;

MYOGLOBIN; NITRIC OXIDE SYNTHASE INHIBITOR; OROSOMUCOID; OSTEOCALCIN; PYROGEN; UREMIC TOXIN; WATER;

BLOOD VOLUME; CARDIOVASCULAR RISK; COMORBIDITY; DATA ANALYSIS; DIALYSATE; DIALYSIS; FEEDBACK SYSTEM; GLYCATION; HEMODIAFILTRATION; HUMAN; IMMUNE SYSTEM; KIDNEY CLEARANCE; KIDNEY FAILURE; MEDICAL RESEARCH; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SOLUTE; SURVIVAL; TECHNIQUE; ULTRAFILTRATION; UREMIA;

EID: 33746462341     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2006.00266.x     Document Type: Review

References (60)

1. Ledebo I. Principles and practice of hemofiltration and hemodiafiltration. Artif Organs 1998;22:20-5.
2. Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP. Overview of clinical studies in hemodiafiltration: what do we need now? Hemodialysis Int 2006;10:S5-12.
3. European best practice guidelines for hemodialysis produced by the EBPG expert group on hemodialysis. Nephrol Dial Transplant 2002;17:45-62.
4. Pereira BJG, Dinarello CA. Role of cytokines in patients on dialysis. Int J Artif Organs 1995;18:293-304.
5. Lonneman G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif 2000;18:214-23.
6. Henderson LW, Beans E. Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration. Kidney Int 1978;14:522-5.
7. Ledebo I, Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs 1999;23:37-43.
8. Canaud B, Bosc JY, Leray H, et al. On-line haemodiafiltration: state of the art. Nephrol Dial Transplant 1998;13 (S5):S3-S11.
9. Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol 2004;15:3207-14.
10. Smeets E, Kooman J, van der Sande F, et al. Prevention of biofilm formation in dialysis water treatment systems. Kidney Int 2003;63:1574-6.
11. Weber C, Stumvoll HK, Passon S, Falkenhagen D. Monocyte activation and humoral immune response to endotoxins in patients receiving on-line hemodiafiltration therapy. Int J Artif Organs 1998;21:335-40.
12. Guth HJ, Gruska S, Kraatz G. On-line production of ultrapure substitution fluid reduces TNF-alpha- and IL-6 release in patients on hemodiafiltration therapy. Int J Artif Organs 2003;26:181-7.
13. Vaslaki L, Weber C, Mitteregger R, Falkenhagen D. Cytokine induction in patients undergoing regular online hemodiafiltration treatment. Artif Organs 2000;24:514-8.
14. Schiffl H, Lang SM, Stratakis D, Fischer R. Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters. Nephrol Dial Transplant 2001;16:1863-9.
15. Sitter T, Bergner A, Shiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 2000;15:1207-11.
16. Schiffl H, Lang SM, Fischer R. Ultrapure dialysis fluid slows loss of residual renal function in new dialysis patients. Nephrol Dial Transplant 2002;17:1814-8.
17. Maduell F. Hemodiafiltration. Hemodialysis Int 2005;9:47-55.
18. Canaud B, Flavier JL, Argiles A, et al. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contrib Nephrol 1994;108:12-22.
19. Henderson LW. Biophysics of ultrafiltration and hemofiltration. In: Maher JF, ed. Replacement of Renal Function by Dialysis. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1989;300-26.
20. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D. Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney Int 1986;30:429-32.
21. Pedrini LA, De Cristofaro V. On-line mixed hemodiafiltration with a feedback for ultrafiltration control. Effect on middle molecule removal. Kidney Int 2003;64:1505-13.
22. Pedrini LA, Cozzi G, Faranna P, et al. Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss. Kidney Int 2006;69:573-9.
23. Petras D, Fortunato A, Soffiati G, et al. Sequential convective therapies (SCT): a prospective study on feasibility, safety, adequacy and tolerance of on-line hemofiltration and hemodiafiltration in sequence. Int J Artif Organs 2005;28:482-8.
24. Santoro A, Conz PA, De Cristofaro V, et al. Mid-dilution: the perfect balance between convection and diffusion. Contrib Nephrol 2005;149:107-14.
25. Krieter DH, Falkenhain S, Chalabi L, Collins G, Lemke HD, Canaud B. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and postdilution hemodiafiltration. Kidney Int 2005;67:349-56.
26. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif 1998;16:261-8.
27. Panichi V, Manca-Rizza G, Paoletti S, et al. Effects on inflammatory and nutritional markers of haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) versus on-line haemodiafiltration: a cross-over randomized multicentre trial. Nephrol Dial Transplant 2006;21:756-62.
28. Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
29. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi e Trapianto Kidney Int 1999;55:286-93.
30. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000;11:2344-50.
31. Lornoy W, Because I, Billiouw JM, Sierens L, Van Malderen P, D'haenens P. On-line haemodiafiltration. Remarkable removal of β2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000;15 (Suppl. 1):49-54.
32. 2- Microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000;15:58-64.
33. Pedrini LA, De Cristofaro Y, Pagliari B, Sama F. Mixed predilution and postdilution on-line hemodiafiltration compared with the traditional infusion methods. Kidney Int 2000;58:2155-65.
34. Maduell F, Navarro V, Cruz MC, et al. Osteocalcin and myoglobin removal in on-line hemodiafiltration versus low- and high-flux hemodialysis. Am J Kidney Dis 2002;40:582-9.
35. Kim ST, Yamamoto C, Asabe H, Sato T, Takamiya T. Online haemodiafiltration: Effective removal of high molecular weight toxins and improvement in clinical manifestations of chronic haemodialysis patients. Nephrology 1996;2 (Suppl. 1):S183-6.
36. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of the protein-bound solute p-cresol by convective transport: a randomized cross-over study. Am J Kidney Dis 2004;44:278-85.
37. Weissinger EM, Kaiser T, Meert N, et al. Proteomics: a novel tool to unravel the patho-physiology of uraemia. Nephrol Dial Transplant 2004;19:3068-77.
38. Lin CL, Huang CC, Yu CC, Yang HY, Chuang FR, Yang CW. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients. Am J Kidney Dis 2003;42:524-32.
39. Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002;62:301-10.
40. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004;15:442-53.
41. Glorieux G, Helling R, Henle T, et al. In vitro evidence for immune activating effect of specific AGE structures retained in uremia. Kidney Int 2004;66:1873-80.
42. Donauer J, Schweiger C, Rumberger B, Krumme B, Bohler J. Reduction of hypotensive side effects during online haemodiafiltration and low temperature haemodialysis. Nephrol Dial Transplant 2003;18:1616-22.
43. van der Sande FM, Kooman JP, Konings CJ, Leunissen KM. Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001;12:1916.
44. Maduell F, del Pozo C, Garcia H, et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999;14:1202-7.
45. Maeda K, Kobayakawa H, Fujita Y. Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder pain in long-term dialysis patients. Artif Organs 1990;14:321-7.
46. Depner TA. Uremic toxicity: urea and beyond. Semin Dial 2001;14:246-51.
47. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-9.
48. Iseki K, Fukiyama K. Long-term prognosis and incidence of acute myocardial infarction in patients on chronic hemodialysis. Am J Kidney Dis 2000;36:820-5.
49. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.
50. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N; European Uremic Toxin Work Group. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005;2:1048-56.
51. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int 2002;61:2187-92.
52. Leypoldt JK, Cheung AK, Carroll CE, et al. Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis 1999;33:349-55.
53. Hornberger JC, Chernew M, Petersen J, Garber AM. A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992;3:1227-37.
54. Koda Y, Nishi S, Miyazaki S, et al. Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997;52:1096-101.
55. Woods HF, Nandakumar M. Improved outcome for hemodialysis patients treated with high-flux membranes. Nephrol Dial Transplant 2000;15 (Suppl. 1):S36-42.
56. Port FK, Wolfe RA, Hulbert-Shearon TE, et al. Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the USRDS dialysis morbidity and mortality study. Am J Kidney Dis 2001;37:276-86.
57. Cheung AK, Levin NW, Greene T, et al. Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003;14:3251-63.
58. Cheung AK, Rocco MV, Yan G, et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 2006;17:546-55.
59. Canaud B, Bragg-Gresham JL, Marshall MR, et al. Patients receiving hemodiafiltration of hemofiltration have lower mortality risk than patients receiving hemodialysis without replacement fluid (HD) in Europe: the Dialysis Outcomes and Practice Patterns Study (DOPPS) (Abstract). J Am Soc Nephrol 2003;14:31A.
60. Jirka T, Cesare S, di Benedetto A, Chang MP, Ponce P, Richards N. The impact of on-line haemodiafiltration (HDF) on patient survival: results from a large network database. Nephrol Dial Transplant 2005;20:v18-19.